# Thymulin bibliography

> Thymulin bibliography | Nexora Peptide — The Nexora Peptide reading list: thymulin, PAT, animal pain experiments, pituitary-cell findings and the distinct human rheumatology studies.

**Reading list**

My leishmaniasis question has difficult company in the chemistry and endocrine papers.

## Skin, brain and nerve injury

The [mouse skin-infection paper](https://pubmed.ncbi.nlm.nih.gov/12096890/) gives the home essay its question about heightened sensitivity and an unchanged baseline. The [rat brain-endotoxin experiment](https://pubmed.ncbi.nlm.nih.gov/14580936/) changes both route and challenge.

For PAT, the [chronic constriction injury study](https://pubmed.ncbi.nlm.nih.gov/12763077/) and the [brain-endotoxin study](https://pubmed.ncbi.nlm.nih.gov/21059360/) test a thymulin analogue. The [rat inflammatory-pain study involving spinal signalling](https://pubmed.ncbi.nlm.nih.gov/30851702/) uses thymulin itself. The preparation names do useful work for me here: they stop related findings from becoming a single sprawling claim.

## Zinc chemistry and endocrine experiments

The [zinc-interaction review](https://pubmed.ncbi.nlm.nih.gov/18476235/) addresses the peptide's active form. The [human marrow-precursor cell study](https://pubmed.ncbi.nlm.nih.gov/6969145/) concerns T-cell markers in culture, while the [rat pituitary-cell study](https://pubmed.ncbi.nlm.nih.gov/9483196/) measures ACTH release.

The [thymus–neuroendocrine review](https://pubmed.ncbi.nlm.nih.gov/19236333/) gives those connections a wider physiological setting. The [athymic-mouse gene-therapy paper](https://pubmed.ncbi.nlm.nih.gov/21952687/) follows a different preparation into hormone development.

## Human rheumatology studies

The [controlled nonathymulin trials](https://pubmed.ncbi.nlm.nih.gov/3310925/) and the [open FTS-Zn trial](https://pubmed.ncbi.nlm.nih.gov/3427844/) both involved rheumatoid-arthritis patients. Their designs and preparations differ.

The full citation details follow.

## References

[1] Thymulin reduces the hyperalgesia and cytokine upregulation induced by cutaneous leishmaniasis in mice https://pubmed.ncbi.nlm.nih.gov/12096890/
[2] Thymulin reverses inflammatory hyperalgesia and modulates the increased concentration of proinflammatory cytokines induced by i.c.v. endotoxin injection https://pubmed.ncbi.nlm.nih.gov/14580936/
[3] Thymulin treatment attenuates inflammatory pain by modulating spinal cellular and molecular signaling pathways https://pubmed.ncbi.nlm.nih.gov/30851702/
[4] A thymulin analogue peptide with powerful inhibitory effects on pain of neurogenic origin https://pubmed.ncbi.nlm.nih.gov/12763077/
[5] Thymulin related peptide attenuates inflammation in the brain induced by intracerebroventricular endotoxin injection https://pubmed.ncbi.nlm.nih.gov/21059360/
[6] Thymulin stimulates corticotrophin release and cyclic nucleotide formation in the rat anterior pituitary gland https://pubmed.ncbi.nlm.nih.gov/9483196/
[7] The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin https://pubmed.ncbi.nlm.nih.gov/19236333/
[8] Interactions between zinc and thymulin https://pubmed.ncbi.nlm.nih.gov/18476235/
[9] Induction of differentiation in human marrow T cell precursors by the synthetic serum thymic factor, FTS https://pubmed.ncbi.nlm.nih.gov/6969145/
[10] Nonathymulin in rheumatoid arthritis: two double blind, placebo controlled trials https://pubmed.ncbi.nlm.nih.gov/3310925/
[11] An open trial of thymulin (FTS-Zn) in rheumatoid arthritis patients: sequential clinical and immunological follow-up https://pubmed.ncbi.nlm.nih.gov/3427844/
[12] Thymulin-based gene therapy and pituitary function in animal models of aging https://pubmed.ncbi.nlm.nih.gov/21952687/

---

My Nexora Peptide essays follow thymulin’s links between inflammation and sensation in published research, without offering a clinical service or medical advice.